Sign inGet started

Carter Todd Alfred

Insider CIK 1944011 · VYGR Chief Scientific Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VYGR Voyager Therapeutics, Inc. S Sale2026-02-242026-02-264,174$3.76 $15.7K145,718SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2026-02-182026-02-203,301$3.44 $11.4K149,892SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2026-02-102026-02-113,525$3.85 $13.6K153,193SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2026-02-062026-02-10154,000— $0154,000SEC↗
VYGR Voyager Therapeutics, Inc. A Award2026-02-062026-02-1033,000— $0156,718SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2025-02-212025-02-2492,000— $092,000SEC↗
VYGR Voyager Therapeutics, Inc. A Award2025-02-212025-02-2446,000— $0123,718SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2025-02-202025-02-243,305$4.26 $14.1K77,718SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2025-02-112025-02-125,413$4.45 $24.1K81,023SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2025-01-142025-01-151,191$5.13 $6.1K86,436SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2024-02-212024-02-223,365$7.47 $25.1K87,627SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2024-02-202024-02-22602$7.68 $4.6K90,992SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2024-02-092024-02-1677,000— $077,000SEC↗
VYGR Voyager Therapeutics, Inc. A Award2024-02-092024-02-1638,500— $091,594SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2024-01-172024-01-191,266$7.18 $9.1K53,094SEC↗
VYGR Voyager Therapeutics, Inc. M Exercise deriv2023-09-152023-09-185,000— $040,000SEC↗
VYGR Voyager Therapeutics, Inc. M Exercise2023-09-152023-09-185,000$2.85 $14.3K64,860SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2023-09-152023-09-1810,500$8.16 $85.7K54,360SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2023-07-062023-07-105,500$10.80 $59.4K59,860SEC↗
VYGR Voyager Therapeutics, Inc. M Exercise deriv2023-06-302023-07-055,000— $045,000SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2023-06-302023-07-055,000$11.41 $57.0K65,360SEC↗
VYGR Voyager Therapeutics, Inc. M Exercise2023-06-302023-07-055,000$2.85 $14.3K70,360SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2023-03-202023-03-222,193$7.76 $17.0K65,360SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2023-02-172023-02-2268,000— $068,000SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2023-02-172023-02-22738$7.45 $5.5K67,553SEC↗
VYGR Voyager Therapeutics, Inc. A Award2023-02-172023-02-2234,000— $068,291SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2023-02-132023-02-15797$7.67 $6.1K34,291SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2023-01-172023-01-19400$10.34 $4.1K35,088SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2023-01-172023-01-19706$9.57 $6.8K35,488SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2023-01-062023-01-10388$6.41 $2.5K36,194SEC↗
VYGR Voyager Therapeutics, Inc. A Award2022-12-312023-01-10388$5.17 $2.0K36,582SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2022-09-192022-09-21165,000— $0165,000SEC↗